Anthracycline-Based Consolidation May Determine Outcome of Post-Consolidation Immunotherapy in AML
Leukemia and Lymphoma - United Kingdom
doi 10.1080/10428194.2019.1599110
Full Text
Open PDFAbstract
Available in full text
Date
April 17, 2019
Authors
Publisher
Informa UK Limited